Latest News about ABBV
Recent news which mentions ABBV
4 Top Value Stock ETFs for Long-Term Wealth Building
March 19, 2023
From Motley Fool
2 Growth Stocks to Buy Before the Bull Market Arrives
March 16, 2023
From Motley Fool
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
March 15, 2023
From Benzinga
Oracle, AbbVie And This Gold Fund: CNBC's 'Final Trades'
March 14, 2023
From Benzinga
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
March 13, 2023
From Benzinga
3 No-Brainer Dividend Stocks to Buy in March
March 11, 2023
From Motley Fool
3 Surefire Stocks That Are Screaming Buys in March
March 09, 2023
From Motley Fool
From Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
From Benzinga
7 Dividend Kings to Buy for an Uncertain Market Environment
March 06, 2023
From InvestorPlace
2 Top Dividend Kings to Buy for the Long Haul
March 04, 2023
From Motley Fool
2 High-Yield Dividend Stocks to Buy in March
March 04, 2023
From Motley Fool
Could This Humira Biosimilar Be a Winner for Amgen?
March 03, 2023
From Motley Fool
From Motley Fool
From Motley Fool
AbbVie Can Write Diversified Growth Story Without Humira, Rest Of The Business Has Strength, Analyst Says
March 01, 2023
Tickers
ABBV
From Benzinga
3 Top Defensive Stocks to Own for a Focus on Quality
March 01, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.